Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …

Background Selective patient recruitment can produce discrepancies between clinical trial
results and real-world effectiveness. Methods A systematic literature review and meta …

Background Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the
adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits …

Background Oral 5‐aminosalicylic (5‐ASA) preparations were intended to avoid the adverse
effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was …

BACKGROUND & AIMS: Interobserver differences in endoscopic assessments contribute to
variations in rates of response to placebo in ulcerative colitis (UC) trials. We investigated …

ABSTRACT Introduction: For 30 years, 5-aminosalicylic acid (5-ASA) has been the
backbone of therapeutic management in patients with ulcerative colitis (UC). In the biologic …

Aliment Pharmacol Ther 2011; 34: 113–124 Summary Background There is no international
agreement on scoring systems used to measure disease activity in ulcerative colitis, nor is …

Background Oral 5‐aminosalicylic acid (5‐ASA; also known as mesalazine or mesalamine)
preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while …

Background Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the
adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. It was …

Introduction Studies suggest infliximab decreases hospitalization and surgery rates in
Crohn'fs disease (CD). The aim of this analysis was to evaluate adherence to infliximab …